.png)
GLP-1 therapies are a breakthrough for obesity and diabetes, but 58% of patients stop treatment before achieving significant health benefits due to side effects. Even for those completing the therapy, weight often returns quickly once the medication is discontinued. However, it's been proven that coupling GLP-1 therapies with a behavior change program delivers sustained, life-long weight loss, better GLP-1 medication adherence, and myriad health benefits. HabitNu has the Solution.
.png)
.png)
HabitNu’s coaching team and Companion App collaborate with healthcare providers to improve adherence, detect and mitigate adverse events, and deliver lasting weight loss. Our certified health coaches offer personalized, evidence-based guidance, while the app tracks diet, weight, activity, and medication adherence. Supported by the coach and leveraging the latest AI technologies, the app provides real-time feedback and tailored encouragement to keep patients on track with their health goals.
HabitNu enhances GLP-1 therapy for patients, providers, and payers with:
• Better medication adherence and sustained weight loss through personalized, high-touch support.
• Fewer side effects by incorporating habit-forming activity and medication tracking routines to reduce health risks like muscle loss and pancreatitis.
• Improved patient health literacy and self-management for lasting behavior change and better outcomes.
• Lower healthcare costs through proactive guidance, early risk detection and long-term weight-loss strategies.
.png)
